Circulating Progenitor Cells and Coronary Collaterals in Chronic Total Occlusion.

Area of Science:

• Cardiovascular Medicine
• Regenerative Medicine
• Hematology

Background:

• The role of circulating progenitor cells (CPCs) in coronary artery chronic total occlusion (CTO) collateralization remains unclear.
• Investigating CPC levels' association with collateral development and ischemic burden in stable CTO patients.

Purpose of the Study:

• To determine if higher circulating progenitor cell (CPC) counts correlate with enhanced collateral artery formation in patients with coronary chronic total occlusions (CTOs).
• To assess the relationship between CPC levels and the degree of ischemic burden, indicated by high-sensitivity troponin-I (hsTn-I), in CTO patients.

Main Methods:

• Enumeration of CPCs using flow cytometry, identifying CD45^med+ mononuclear cells expressing CD34 and CD34/CD133 epitopes.
• Multivariate regression analysis to evaluate the association between CPC counts, Rentrop collateral grade, and hsTn-I levels, adjusting for clinical factors.

Main Results:

• Higher CPC counts (CD34+ and CD34+/CD133+) were positively associated with greater Rentrop collateral grade (P=0.082 and P=0.028, respectively).
• Each doubling of CPC counts correlated with significantly lower hsTn-I levels (P=0.002 for CD34+ and P=0.009 for CD34+/CD133+).

Conclusions:

• Elevated circulating progenitor cell (CPC) levels are associated with improved collateral development in coronary artery chronic total occlusions (CTOs).
• Higher CPC counts indicate a lower ischemic burden in patients presenting with CTOs.